RO
Ross Osborn Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
18
Avg Return
Past Year
Past Year
4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $13 |
161%
upside
| 2 | +4.8% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $32 |
54%
upside
| 1 | +79% |
0
%
| 29 Oct ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $9 |
273%
upside
| 2 | -21% |
0
%
| 8 Aug ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $95 |
3%
upside
| 1 | – |
–
| 6 Aug ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| $25 |
65%
upside
| 2 | -0.96% |
0
%
| 5 Aug ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $12 |
226%
upside
| 2 | -18% |
0
%
| 31 Jul ‘25 10 months ago |
|
|
|
Overweight
Initiated
| $12 |
40%
upside
| 1 | +27% |
0
%
| 7 Jul ‘25 11 months ago |
|